Subgroups | No. of studies | No. of patients | HR (95%CI) | p | Effects model | Heterogeneity | |
---|---|---|---|---|---|---|---|
I2(%) | Ph | ||||||
Total | 13 | 3515 | 1.77 (1.47–2.14) | <0.001 | Random | 56.2 | 0.007 |
Countries | |||||||
 Asian | 10 | 2,464 | 1.97 (1.54–2.54) | <0.001 | Random | 54.3 | 0.020 |
 Non-Asian | 3 | 1,051 | 1.47 (1.14–1.90) | 0.003 | Random | 50.9 | 0.130 |
Sample size | |||||||
 ≤140 | 7 | 693 | 2.31 (1.59–3.36) | <0.001 | Random | 63.7 | 0.011 |
 >140 | 6 | 2,822 | 1.55 (1.25–1.93) | <0.001 | Random | 52.4 | 0.062 |
Histology | |||||||
 BTC | 2 | 218 | 1.97 (0.42–9.30) | 0.394 | Random | 90.3 | 0.001 |
 ECC | 3 | 485 | 1.49 (1.08–2.05) | 0.014 | Fixed | 23.9 | 0.269 |
 ICC | 5 | 1,505 | 1.65 (1.42–1.92) | <0.001 | Fixed | 36.5 | 0.178 |
 GBC | 3 | 1,307 | 2.00 (1.58–2.51) | <0.001 | Fixed | 48.2 | 0.145 |
TNM stage | |||||||
 I–III | 6 | 2,651 | 1.96 (1.67–2.30) | <0.001 | Fixed | 0 | 0.483 |
 I–IV | 4 | 618 | 1.42 (1.19–1.69) | <0.001 | Fixed | 0 | 0.524 |
 IV | 3 | 246 | 2.33 (0.72–7.57) | 0.160 | Random | 84.5 | 0.002 |
Treatment | |||||||
 Surgery | 10 | 3,184 | 1.70 (1.51–1.92) | <0.001 | Fixed | 41.8 | 0.079 |
 Non-surgery | 3 | 331 | 1.81 (0.82–4.04) | 0.144 | Random | 82.0 | 0.004 |
Cutoff value | |||||||
 ≤600 | 7 | 2,275 | 1.59 (1.35–1.87) | <0.001 | Fixed | 47.8 | 0.074 |
 >600 | 6 | 1,240 | 2.17 (1.55–3.03) | <0.001 | Random | 67.1 | 0.009 |
Survival analysis | |||||||
 Multivariate | 9 | 2,979 | 1.81 (1.57–2.09) | <0.001 | Fixed | 47.8 | 0.053 |
 Univariate | 4 | 536 | 1.64 (1.10–2.45) | 0.016 | Random | 65.5 | 0.034 |